相关实验视频
Updated: Jan 17, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
909
对于同时使用可卡因障碍和肥胖症的纳尔特雷-布普罗联合治疗:一个案例报告
1Department of Culture and Society, University of Palermo, Viale Delle Scienze, Ed. 15, 90128 Palermo, Italy.
Reports (MDPI)
|September 22, 2025
概括
固定的剂量纳尔特雷-布罗 (NB) 有效地减少了可卡因的渴望,并促进了可卡因使用障碍 (CUD) 和肥胖症患者的体重减轻. 这种双重作用疗法在治疗同时发生的CUD和体重管理方面表现有前途.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成 药物 药物 药物 药物
背景情况:
- 可卡因使用障碍 (CUD) 涉及强烈的渴望和强迫性使用,通常与肥胖同时发生.
- 固定剂量纳尔特雷-布洛 (NB) 组合向μ-阿片类受体对抗性和布洛对CUD和体重管理的 катехоламин的作用.
- 了解中和下丘脑路径之间的相互作用对于治疗同时发生的CUD和肥胖至关重要.
研究的目的:
- 介绍一个用固定的剂量治疗CUD和肥胖症患者的案例研究NB.
- 评估NB在减少可卡因渴望和促进减肥方面的有效性.
- 在这个患者群体中评估NB的安全性和耐受性.
主要方法:
- 一名35岁的男性有10年的CUD和肥胖病史 (BMI 31 kg/m2) 在门诊环境中接受固定剂量NB治疗.
- 患者被跟踪了12周,评估了可卡因渴望 (CCQ-B分数) 和体重指数 (BMI).
- 在整个治疗期间,监测药物服药,精神稳定性和安全问题.
主要成果:
- 经过NB治疗,可卡因诱导反应的渴望显著减少,CCQ-B得分下降约70% (从7.2降至2.1).
- 观察到临床上有意义的体重减轻,BMI下降约17.7% (从31.0到25.5公斤/米2).
- 患者保持了禁欲,表现出更好的食欲控制和心理社会功能,药物坚持稳定,没有精神病失稳或安全问题.
结论:
- 本案例研究支持NB在治疗同时发生的CUD和肥胖症时的双重目标逻辑.
- NB治疗同时减轻了可卡因渴望和促进体重控制.
- 需要进一步进行受控试验,以调查NB在患有同时出现CUD和肥胖症的患者中的治疗潜力.
相关概念视频
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Binge Eating Disorders
426
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
426
Bulimia Nervosa
692
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
692

